Expediting drug development through the use of plants

被引：0
|
作者：
Hylands, PJ [1 ]
机构：
[1] Oxford Nat Prod PLC, Oxford OX1 3JS, England
来源：
BIOASSAY METHODS IN NATURAL PRODUCT RESEARCH AND DRUG DEVELOPMENT | 1999年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：167 / 181
页数：15
相关论文
共 50 条
  • [31] Relationship between human development and drug use. Human development index and drug use
    Salazar Silva, Fernando
    Villatoro Velazquez, Jorge Ameth
    Oliva Robles, Natania Froylan
    Hynes, Marya
    de Marco, Maria
    SALUD MENTAL, 2014, 37 (01) : 35 - 39
  • [32] Intense bitterness of molecules: Machine learning for expediting drug discovery
    Margulis, Eitan
    Dagan-Wiener, Ayana
    Ives, Robert S.
    Jaffari, Sara
    Siems, Karsten
    Niv, Masha Y.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 568 - 576
  • [33] EXPEDITING MEDICAL RECORD CHARTING BY USE OF ADHESIVE LABELS
    HEATH, MK
    JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1988, 88 (01) : 61 - 63
  • [34] HIGHER-PLANTS - SLEEPING GIANT OF DRUG DEVELOPMENT
    FARNSWORTH, NR
    MORRIS, RW
    AMERICAN JOURNAL OF PHARMACY, 1976, 148 (02): : 46 - 52
  • [35] EXPEDITING ML/AI DEVELOPMENT AND DEPLOYMENT WITH TEMPLATED MLOPS
    Godwin, Ryan C.
    Melvin, Ryan L.
    ANESTHESIA AND ANALGESIA, 2024, 138
  • [36] Phase 0 Trials: Expediting the Development of Chemoprevention Agents
    Kummar, Shivaani
    Doroshow, James H.
    CANCER PREVENTION RESEARCH, 2011, 4 (03) : 288 - 292
  • [37] Dementia drug development: Use of information systems to harmonize global drug development
    Whitehouse, PJ
    Sciulli, CG
    Mason, RM
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (01) : 129 - 133
  • [38] The use of imaging in preclinical drug development
    Vanderheyden, J-L
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 53 (04): : 374 - 381
  • [39] The use of imaging to accelerate drug development
    Aboagye, E
    DRUG DISCOVERY TODAY, 2002, 7 (13) : 706 - 707
  • [40] Use of imaging and genetics in drug development
    Bertolino, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S126 - S126
12345